cjc-1295 ipamorelin promote lipolysis + Ipamorelin: Boost Recovery and Performance CJC-1295 (NO DAC) + Ipamorelin

Potential Research Observations: Enhanced anabolic signaling and protein synthesis in target tissues [1]

IGF-1 elevation requires monitoring Both peptides elevate IGF-1 levels

First described by Novo Nordisk researchers, ipamorelin is notable for its selectivity in stimulating growth hormone release without significantly affecting other pituitary hormones such as ACTH, prolactin, FSH, LH, or TSH in preclinical models

Product Transparency 40 years of research dedicated to bringing you premium, scientifically-validated formulations

These effects typically resolve within 2-3 weeks as detoxification pathways establish new equilibrium

This can be advantageous for athletes and fitness enthusiasts looking to optimize their physique and performance